Research Providing Possible New Therapeutic Option for Improving Bronchopulmonary Dysplasia Highlighted

Mohammad Afaque Alam, PhD, Associate Scientist in the Sol Sherry Thrombosis Research Center at the Lewis Katz School of Medicine at Temple University, was the first author of the research team that used a mouse model of hyperoxia-induced lung injury and bronchopulmonary dysplasia patients to investigate the expression profile and functional role of microRNA199a-5p after hyperoxia. The team’s study results indicate that miR199a-5p inhibitors might be a new therapeutic option for improving bronchopulmonary dysplasia in preterm newborns. The findings were selected to be highlighted in the “Editor’s Focus” of November’s Pediatric Research.